Cytokinetics (NASDAQ:CYTK – Get Rating) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday. A number of other research firms also recently issued reports on CYTK. Mizuho initiated coverage on shares of Cytokinetics in a research report on Monday, March 6th. […]
Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cytokinetics (NASDAQ:CYTK – Get Rating) posted its earnings results on Thursday. The biopharmaceutical company reported ($1.38) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.24) by ($0.14), Briefing.com reports. Cytokinetics had a negative return on equity of 1,401.63% and a negative net margin of 439.05%. The company had revenue of $4.60 […]
Cytokinetics (NASDAQ:CYTK – Get Rating) released its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.38) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.24) by ($0.14), Briefing.com reports. The company had revenue of $4.60 million for the quarter, compared to analyst estimates of $2.50 million. Cytokinetics had a negative return […]
Cytokinetics (NASDAQ:CYTK – Get Rating) announced its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.38) EPS for the quarter, missing analysts’ consensus estimates of ($1.24) by ($0.14), Briefing.com reports. Cytokinetics had a negative net margin of 410.89% and a negative return on equity of 1,401.63%. The firm had revenue of $4.60 million during […]